期刊文献+

细胞外信号调节激酶在5-氨基酮戊酸光动力疗法杀伤SCL-1细胞中的作用 被引量:2

The Effect of Extracellular Signal-regulated Kinase (ERK1/2) in ALA-PDT Killing SCL-1 Cell
原文传递
导出
摘要 目的探讨阻断细胞外信号调节激酶通路后对5-氨基酮戊酸光动力疗法(ALA-PDT)杀伤人皮肤鳞状细胞癌细胞株(SCL-1)细胞的影响。方法将SCL-1细胞分为空白对照组、激光照射组、ALA组、ALA-PDT组及ERK阻断剂组。Western蛋白印迹法检测各组细胞干预30min,60min,90min后细胞外信号调节激酶1/2(ERK1/2)蛋白产物及磷酸化细胞外信号调节激酶1/2(p-ERK1/2)蛋白产物的表达;用MTT(噻唑蓝)酶联免疫法分别检测各组细胞在干预后24h,48h,72h的光密度值,计算各组细胞存活率;用Annexin V-FITC/PI双染流式细胞术检测各组细胞干预后24h,48h,72h细胞的凋亡率。结果与其余各组相比,ERK阻断剂组p-ERK1/2蛋白表达水平有明显下降;ERK阻断剂组细胞的存活率显著下降;ERK阻断剂组细胞的早期凋亡率明显增高,差异均有统计学意义(P<0.05)。结论阻断ERK通路可能成为增强ALA-PDT杀伤皮肤鳞癌细胞新的治疗靶点。 Objective To explore the effect of blocking extracellular signal-regulated kinase(ERK1/2) pathway on the duration of 5-aminolevulinic acid(ALA) photodynamic therapy (PDT) killing SCL-1 cells. Methods SCL-1 cells were divided into control group, light group, ALA group, ALA-PDT group and inhibitor of ERK group. Western blotting technique was used to detect the expression of ERK1/2 and p-ERK1/2 after interve-ning 30min, 60min and 90min of each cell groups. MTT was used to calculated the cell survival rate after optical density value of each group were obtained at 24h,48h,72h. Flow cytometry with annexin V-FITC/PI double staining technique was employed to detect apoptosis of each cell after intervening 24h,48h and 72h. Results When compared with control group, ALA group, light group, and inhibitor of ERK group, inhibi-tor of ERK group can obviously decrease the expression of phospho-ERK1/2 ( P 〈 0.05 ) and the cell survival rate (P 〈 0.05 ) ; inhibitor of ERK group can sharply increase the rate of apoptosis ( P 〈 0.05 ) . Conclusion Blocking ERK pathway may become a new therapeutic target to enhance the treatment of ALA-PDT on squamous cell carcinoma.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2013年第5期435-439,共5页 The Chinese Journal of Dermatovenereology
基金 国家自然科学基金资助项目(81060181) 宁夏自然科学基金资助项目(NZ1222)
关键词 5-氨基酮戊酸 光动力疗法 SCL-1细胞 细胞外信号调节激酶(ERK1 2) ERK阻断剂 ALA PDT SCL-1 cell ERK pathway Inhibitor of ERK
  • 相关文献

参考文献13

  • 1Simone CB 2nd, Friedberg JS, Glatstein E, et al. Photodynamic therapy for the treatment of non-small cell lung cancer [ J ]. Thorac Dis, 2012,4( 1 ) :63 -75.
  • 2李伯埙.现代皮肤性病学[M].西安:世界图书出版公司,2007:821-823.
  • 3Mirzoeva OK, Das D, Heiser LM, et al. Basal subtype and eptibility of breast cancer ceils to MEK inhibition [ J ]. Cancer Res, 2009,2 (69) :565 -572.
  • 4Lu Z, Ding L, Hong H, et al. Clandin-7 inhibits human lung cancer cell migration and invasion through ERK/MAPK signaling pathway [J] Exp Cell Res, 2011,317(13) :1935 -1946.
  • 5王丽,栗玉珍.黑素瘤的分子发病机制和靶向治疗新进展[J].中国皮肤性病学杂志,2012,26(2):164-166. 被引量:9
  • 6Zhang X, Makino T, Muchemwa FC, et al. Activation of the extracellular signal-regulated kinases signaling pathway in squamous cell carcinoma of the skin [ J ]. Biosci Trends, 2007,1 (3) : 156 - 160.
  • 7Donnelly RF, McCarron PA, Woolfson AD. Derivatives of 5-aminole- vulinic Acid for photodynamic therapy [ J ]. Perspect Medicin Chem, 2008,11(1) : 49 -63.
  • 8Ahn TG, Lee BR, Choi EY, et al. Photodynamic therapy for breast cancer in a BALB/c mouse model [ J ]. J Gynecol Oncol, 2012,2 (23) :115 -119.
  • 9郑江华,时德,赵渝,陈祖林.细胞外信号调节激酶通路激活抑制δ氨基酮戊酸-光动力疗法对SW480细胞的细胞毒作用[J].重庆医科大学学报,2006,31(4):482-485. 被引量:4
  • 10Tong Z, SinghG, Rainbow AJ. Sustained activation ofthe extracellular signal-regulated kinase pathway protects cells from photofrin-media- ted photodynamic therapy [ J ]. Cancer Res ,2002,62 (19) : 5528 - 5535.

二级参考文献40

  • 1郑江华,时德,陈祖林.δ氨基酮戊酸光动力疗法对人结肠癌细胞SW480游离钙浓度的影响[J].中华实验外科杂志,2005,22(2):250-250. 被引量:6
  • 2Gray-Schopfer V,Wellbrock C,Marais R.Melanoma biology and new targeted therapy[J].Nature,2007,445(7130):851-857.
  • 3Dhomen N,Marais R.BRAF signaling and targeted therapies in melanoma[J].Hematol Oncol Clin North Am,2009,23(3):529-545.
  • 4Lopez-Bergami P,Fitchman B,Ronai Z.Understanding signaling cascades in melanoma[J].Photochem Photobiol,2008,84(2):289-306.
  • 5McCubrey JA,Steelman LS,Abrams SL,et al.Emerging Raf Inhibitors[J].Expert Opin Emerg Drugs,2009,14(4):633-648.
  • 6McCubrey JA,Steelman LS,Chappell WH,et al.Roles of the Raf/MEK/ERK pathway in cell growth,malignant transformation and drug resistance[J].Biochim Biophys Acta,2007,1773(8):1263-1284.
  • 7Dahl C,Guldberg P.The genome and epigenome of malignant melanoma[J].APMIS,2007,115(10):1161-1176.
  • 8Goel VK,Lazar A J,Warneke CL,et al.Examination of mutations in BRAF,NRAS,and PTEN in primary cutaneous melanoma[J].J Invest Dermato1,2006,126(1):154-160.
  • 9Halilovic E,Solit DB.Therapeutic strategies for inhibiting oncogenic BRAF signaling[J].Curr Opin Pharmacol,2008,8(4):419-426.
  • 10Yann Cheli,Mickae Ohanna,Robert Ballotti,et al.Fifteen-year quest for microphthalmia-associated transcription factor target genes[J].Pigment Cell Melanoma Res,2010,23(1):27-40.

共引文献11

同被引文献3

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部